SCHEMBL5964571

SCHEMBL5964571

Cc1cc(Oc2c(Br)cc(CC(=O)c3ccccc3N(C)CC(=O)O)cc2Br)cc(C(C)C)c1O

nearest known ligand 0.55

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
THRA P10827 16/20 0.55
THRB P10828 16/20 0.55
NR3C1 P04150 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5278519 0.92 THRB (0.43) THRATHRB
SCHEMBL5964859 0.85 THRB (0.45) THRATHRBNR3C1
SCHEMBL4529612 0.82 THRA (0.58) THRATHRB
SCHEMBL5292931 0.81 THRA (0.62) THRATHRB
SCHEMBL5287547 0.80 THRB (0.73) THRATHRB
SCHEMBL5275174 0.76 THRA (0.59) THRATHRB
SCHEMBL5964575 0.75 THRA (0.61) THRATHRB
SCHEMBL4353708 0.75 THRA (0.64) THRATHRB
SCHEMBL5281234 0.74 THRA (0.70) THRATHRB
SCHEMBL5964578 0.73 THRA (0.67) THRATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7153997-B2 Benzamide derivatives as thyroid receptor ligands KARO BIO AB (SE) 2006-12-26 US disclosed
US-20060135614-A1 Novel compounds NORIN, THOMAS ANDERS WILSON (SE) 2006-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060135614-A1 Novel compounds THRB, TSHR, THRA THRA 3/4885THRB 1/4885NR3C1 39/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.